Verified earnings results

Atrium Therapeutics Q3 2026 Earnings Results

Direct answer

Atrium Therapeutics reported Q3 2026 results on November 12, 2026.

Revenue was 15,321,000. EPS beat the estimate by 69.44%.
The result is verified against Verified earnings source.
Verified earnings source

Get free Atrium Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 12, 2026
Reported timing
After the US market closes
EPS estimate
-0.8181
Reported EPS
-0.25
Revenue
15,321,000
EPS surprise
EPS beat the estimate by 69.44%.

Read the frequently asked questions.

When did Atrium Therapeutics report Q3 2026 earnings?

Atrium Therapeutics reported on November 12, 2026. The reported timing was after the us market closes.

What is the available EPS estimate for Atrium Therapeutics?

The verified record provides an EPS estimate of -0.8181.

Has Atrium Therapeutics reported the Q3 2026 result?

Revenue was 15,321,000. EPS beat the estimate by 69.44%.

Which source supports this Atrium Therapeutics earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.